Sat. Nov 23rd, 2024

Dementia Education Psychiatry

Eisai’s Leqembi: Addressing the risks, benefits of Alzheimer’s drug

Bydashephe

Jul 13, 2023 #AD, #alzheimers, #dementia

https://www.statnews.com/2023/06/16/the-fda-needs-a-risk-evaluation-and-mitigation-strategy-for-alzheimers-drug-lecanemab/

By dashephe

Related Post

Abx Stewardship Education Infxn Control Internal Med Uncategorized

Antibiotic Stewardship – Antibiotic awareness week Nov 18-24, 2024; FOR PROVIDERS.

Nov 4, 2024 dashephe

Dementia Psychiatry

Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study | The BMJ

Sep 20, 2024 dashephe

Abx Stewardship Education

Kentucky Antibiotic Stewardship Innovation Consortium

Sep 19, 2024 dashephe

You missed

CMS Regulations

Surveyor Guidance Update 11-18-24

November 20, 2024 dashephe

Assessment of Behavioral/Psychological Symptoms of Dementia Guidelines and Implementation | Psychiatry Online

November 20, 2024 dashephe

Pain Assessment Information | GeriatricPain.org – The University of Iowa

November 20, 2024 dashephe

C auris Infxn Control

Candida auris outbreak in a long-term acute care hospital | November 15, 2024

November 16, 2024 dashephe